世界のミトコンドリア病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mitochondrial Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5865
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ミトコンドリア病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダイエット療法、ビタミン・サプリメント療法、パイプライン療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ミトコンドリア病治療の市場動向
・企業の競争状況、市場シェア
・ミトコンドリア病治療の種類別市場規模と予測2016-2027（ダイエット療法、ビタミン・サプリメント療法、パイプライン療法、その他）
・ミトコンドリア病治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・ミトコンドリア病治療の北米市場規模2016-2027（アメリカ、カナダ）
・ミトコンドリア病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ミトコンドリア病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ミトコンドリア病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ミトコンドリア病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Khondrion、Mitobridge、NeuroVive Pharmaceutical、Reata Pharmaceuticals、Stealth Biotherapeutics、Centogene、GeneDx、Ixchel Pharma）
・結論

Mitochondrial disorders are inherited chronic disorders characterized by a wide range of biochemical and genetic mitochondrial defects and mutations. The disorder affects multiple organs, which includes brain, heart, liver, skeletal muscles, kidney, and respiratory systems.

Market Analysis and Insights: Global Mitochondrial Disorders Treatment Market
The global Mitochondrial Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mitochondrial Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mitochondrial Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mitochondrial Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mitochondrial Disorders Treatment market.

Global Mitochondrial Disorders Treatment Scope and Market Size
Mitochondrial Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mitochondrial Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dietary Therapy
Vitamin and Supplement Therapy
Pipeline Therapies
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Khondrion
Mitobridge
NeuroVive Pharmaceutical
Reata Pharmaceuticals
Stealth Biotherapeutics
Centogene
GeneDx
Ixchel Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mitochondrial Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dietary Therapy
1.2.3 Vitamin and Supplement Therapy
1.2.4 Pipeline Therapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Mitochondrial Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mitochondrial Disorders Treatment Market Perspective (2016-2027)
2.2 Mitochondrial Disorders Treatment Growth Trends by Regions
2.2.1 Mitochondrial Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mitochondrial Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mitochondrial Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mitochondrial Disorders Treatment Industry Dynamic
2.3.1 Mitochondrial Disorders Treatment Market Trends
2.3.2 Mitochondrial Disorders Treatment Market Drivers
2.3.3 Mitochondrial Disorders Treatment Market Challenges
2.3.4 Mitochondrial Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mitochondrial Disorders Treatment Players by Revenue
3.1.1 Global Top Mitochondrial Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Mitochondrial Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mitochondrial Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mitochondrial Disorders Treatment Revenue
3.4 Global Mitochondrial Disorders Treatment Market Concentration Ratio
3.4.1 Global Mitochondrial Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mitochondrial Disorders Treatment Revenue in 2020
3.5 Mitochondrial Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Mitochondrial Disorders Treatment Product Solution and Service
3.7 Date of Enter into Mitochondrial Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mitochondrial Disorders Treatment Breakdown Data by Type
4.1 Global Mitochondrial Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mitochondrial Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Mitochondrial Disorders Treatment Breakdown Data by Application
5.1 Global Mitochondrial Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mitochondrial Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mitochondrial Disorders Treatment Market Size (2016-2027)
6.2 North America Mitochondrial Disorders Treatment Market Size by Type
6.2.1 North America Mitochondrial Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Mitochondrial Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Mitochondrial Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Mitochondrial Disorders Treatment Market Size by Application
6.3.1 North America Mitochondrial Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Mitochondrial Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Mitochondrial Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Mitochondrial Disorders Treatment Market Size by Country
6.4.1 North America Mitochondrial Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Mitochondrial Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Mitochondrial Disorders Treatment Market Size (2016-2027)
7.2 Europe Mitochondrial Disorders Treatment Market Size by Type
7.2.1 Europe Mitochondrial Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mitochondrial Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mitochondrial Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Mitochondrial Disorders Treatment Market Size by Application
7.3.1 Europe Mitochondrial Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mitochondrial Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mitochondrial Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Mitochondrial Disorders Treatment Market Size by Country
7.4.1 Europe Mitochondrial Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mitochondrial Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mitochondrial Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mitochondrial Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mitochondrial Disorders Treatment Market Size (2016-2027)
9.2 Latin America Mitochondrial Disorders Treatment Market Size by Type
9.2.1 Latin America Mitochondrial Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mitochondrial Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mitochondrial Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Mitochondrial Disorders Treatment Market Size by Application
9.3.1 Latin America Mitochondrial Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mitochondrial Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mitochondrial Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Mitochondrial Disorders Treatment Market Size by Country
9.4.1 Latin America Mitochondrial Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mitochondrial Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mitochondrial Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mitochondrial Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Khondrion
11.1.1 Khondrion Company Details
11.1.2 Khondrion Business Overview
11.1.3 Khondrion Mitochondrial Disorders Treatment Introduction
11.1.4 Khondrion Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.1.5 Khondrion Recent Development
11.2 Mitobridge
11.2.1 Mitobridge Company Details
11.2.2 Mitobridge Business Overview
11.2.3 Mitobridge Mitochondrial Disorders Treatment Introduction
11.2.4 Mitobridge Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.2.5 Mitobridge Recent Development
11.3 NeuroVive Pharmaceutical
11.3.1 NeuroVive Pharmaceutical Company Details
11.3.2 NeuroVive Pharmaceutical Business Overview
11.3.3 NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Introduction
11.3.4 NeuroVive Pharmaceutical Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.3.5 NeuroVive Pharmaceutical Recent Development
11.4 Reata Pharmaceuticals
11.4.1 Reata Pharmaceuticals Company Details
11.4.2 Reata Pharmaceuticals Business Overview
11.4.3 Reata Pharmaceuticals Mitochondrial Disorders Treatment Introduction
11.4.4 Reata Pharmaceuticals Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.4.5 Reata Pharmaceuticals Recent Development
11.5 Stealth Biotherapeutics
11.5.1 Stealth Biotherapeutics Company Details
11.5.2 Stealth Biotherapeutics Business Overview
11.5.3 Stealth Biotherapeutics Mitochondrial Disorders Treatment Introduction
11.5.4 Stealth Biotherapeutics Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.5.5 Stealth Biotherapeutics Recent Development
11.6 Centogene
11.6.1 Centogene Company Details
11.6.2 Centogene Business Overview
11.6.3 Centogene Mitochondrial Disorders Treatment Introduction
11.6.4 Centogene Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.6.5 Centogene Recent Development
11.7 GeneDx
11.7.1 GeneDx Company Details
11.7.2 GeneDx Business Overview
11.7.3 GeneDx Mitochondrial Disorders Treatment Introduction
11.7.4 GeneDx Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.7.5 GeneDx Recent Development
11.8 Ixchel Pharma
11.8.1 Ixchel Pharma Company Details
11.8.2 Ixchel Pharma Business Overview
11.8.3 Ixchel Pharma Mitochondrial Disorders Treatment Introduction
11.8.4 Ixchel Pharma Revenue in Mitochondrial Disorders Treatment Business (2016-2021)
11.8.5 Ixchel Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mitochondrial Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dietary Therapy
Table 3. Key Players of Vitamin and Supplement Therapy
Table 4. Key Players of Pipeline Therapies
Table 5. Key Players of Others
Table 6. Global Mitochondrial Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mitochondrial Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Mitochondrial Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Mitochondrial Disorders Treatment Market Share by Regions (2016-2021)
Table 10. Global Mitochondrial Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Mitochondrial Disorders Treatment Market Share by Regions (2022-2027)
Table 12. Mitochondrial Disorders Treatment Market Trends
Table 13. Mitochondrial Disorders Treatment Market Drivers
Table 14. Mitochondrial Disorders Treatment Market Challenges
Table 15. Mitochondrial Disorders Treatment Market Restraints
Table 16. Global Mitochondrial Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Mitochondrial Disorders Treatment Market Share by Players (2016-2021)
Table 18. Global Top Mitochondrial Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Disorders Treatment as of 2020)
Table 19. Ranking of Global Top Mitochondrial Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Mitochondrial Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mitochondrial Disorders Treatment Product Solution and Service
Table 23. Date of Enter into Mitochondrial Disorders Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Mitochondrial Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Mitochondrial Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Mitochondrial Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Mitochondrial Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Mitochondrial Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Mitochondrial Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Mitochondrial Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Mitochondrial Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Mitochondrial Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Mitochondrial Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Mitochondrial Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Mitochondrial Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Mitochondrial Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Mitochondrial Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Mitochondrial Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Mitochondrial Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Mitochondrial Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Mitochondrial Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Mitochondrial Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Mitochondrial Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Mitochondrial Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Mitochondrial Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Mitochondrial Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Mitochondrial Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Khondrion Company Details
Table 64. Khondrion Business Overview
Table 65. Khondrion Mitochondrial Disorders Treatment Product
Table 66. Khondrion Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 67. Khondrion Recent Development
Table 68. Mitobridge Company Details
Table 69. Mitobridge Business Overview
Table 70. Mitobridge Mitochondrial Disorders Treatment Product
Table 71. Mitobridge Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 72. Mitobridge Recent Development
Table 73. NeuroVive Pharmaceutical Company Details
Table 74. NeuroVive Pharmaceutical Business Overview
Table 75. NeuroVive Pharmaceutical Mitochondrial Disorders Treatment Product
Table 76. NeuroVive Pharmaceutical Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 77. NeuroVive Pharmaceutical Recent Development
Table 78. Reata Pharmaceuticals Company Details
Table 79. Reata Pharmaceuticals Business Overview
Table 80. Reata Pharmaceuticals Mitochondrial Disorders Treatment Product
Table 81. Reata Pharmaceuticals Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 82. Reata Pharmaceuticals Recent Development
Table 83. Stealth Biotherapeutics Company Details
Table 84. Stealth Biotherapeutics Business Overview
Table 85. Stealth Biotherapeutics Mitochondrial Disorders Treatment Product
Table 86. Stealth Biotherapeutics Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 87. Stealth Biotherapeutics Recent Development
Table 88. Centogene Company Details
Table 89. Centogene Business Overview
Table 90. Centogene Mitochondrial Disorders Treatment Product
Table 91. Centogene Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 92. Centogene Recent Development
Table 93. GeneDx Company Details
Table 94. GeneDx Business Overview
Table 95. GeneDx Mitochondrial Disorders Treatment Product
Table 96. GeneDx Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 97. GeneDx Recent Development
Table 98. Ixchel Pharma Company Details
Table 99. Ixchel Pharma Business Overview
Table 100. Ixchel Pharma Revenue in Mitochondrial Disorders Treatment Business (2016-2021) & (US$ Million)
Table 101. Ixchel Pharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mitochondrial Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. Dietary Therapy Features
Figure 3. Vitamin and Supplement Therapy Features
Figure 4. Pipeline Therapies Features
Figure 5. Others Features
Figure 6. Global Mitochondrial Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Mitochondrial Disorders Treatment Report Years Considered
Figure 11. Global Mitochondrial Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Mitochondrial Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Mitochondrial Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Mitochondrial Disorders Treatment Market Share by Regions (2022-2027)
Figure 15. Global Mitochondrial Disorders Treatment Market Share by Players in 2020
Figure 16. Global Top Mitochondrial Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mitochondrial Disorders Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Mitochondrial Disorders Treatment Revenue in 2020
Figure 18. Global Mitochondrial Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Mitochondrial Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Mitochondrial Disorders Treatment Market Share by Type (2016-2027)
Figure 22. North America Mitochondrial Disorders Treatment Market Share by Application (2016-2027)
Figure 23. North America Mitochondrial Disorders Treatment Market Share by Country (2016-2027)
Figure 24. United States Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Mitochondrial Disorders Treatment Market Share by Type (2016-2027)
Figure 28. Europe Mitochondrial Disorders Treatment Market Share by Application (2016-2027)
Figure 29. Europe Mitochondrial Disorders Treatment Market Share by Country (2016-2027)
Figure 30. Germany Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Mitochondrial Disorders Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Mitochondrial Disorders Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Mitochondrial Disorders Treatment Market Share by Region (2016-2027)
Figure 40. China Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Mitochondrial Disorders Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Mitochondrial Disorders Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Mitochondrial Disorders Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Mitochondrial Disorders Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Mitochondrial Disorders Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Mitochondrial Disorders Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Mitochondrial Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Khondrion Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 60. Mitobridge Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 61. NeuroVive Pharmaceutical Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 62. Reata Pharmaceuticals Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 63. Stealth Biotherapeutics Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 64. Centogene Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 65. GeneDx Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 66. Ixchel Pharma Revenue Growth Rate in Mitochondrial Disorders Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Urea Cycle Disorders (UCD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5000 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、尿素サイクル異常症（UCD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アミノ酸式、フェニル酪酸、安息香酸ナトリウム、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別...

世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年）

Global Frontotemporal Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4238 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、前頭側頭型認知症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（向知性薬、抗精神病薬、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（...

世界のシトクロムP45011B2ミトコンドリア市場規模・現状・予測（2021年-2027年）

Global Cytochrome P450 11B2 Mitochondrial Market Size, Status and Forecast 2021-2027
QFJ1-5688 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、シトクロムP45011B2ミトコンドリアの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DP-13、BI-689648、リン酸オシロドロスタット、その他）、用途別市場規模（高血圧、腎線維化、心筋線維化...

世界の上肢障害治療市場規模・現状・予測（2021年-2027年）

Global Upper Extremities Disorders Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4999 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、上肢障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（置換＆骨折、神経疾患、軟部組織損傷）、用途別市場規模（病院・外科センター、整形外科センター、外科医院）、主要地域別市場規模（北米、アメリカ、...

世界の神経疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4568 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、神経疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（中枢神経系（CNS）、末梢神経系（PNS））、用途別市場規模（麻痺、筋力低下、協調運動不全、感覚喪失、発作、錯乱、疼痛、意識レベル変化）、...

世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年）

Global Female Sexual Dysfunction Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5740 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、女性性機能障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（性的欲求障害、性的覚醒障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Inherited Genetic Disorders Market Size, Status and Forecast 2021-2027
QFJ1-4248 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、遺伝性遺伝性疾患用遺伝子治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼疾患、造血系疾患、中枢神経系疾患、筋肉疾患、その他）、用途別市場規模（病院、診療所、研究所、その他）、主要地域別市場規模（...

世界のバイオパンクチャー治療市場規模・現状・予測（2021年-2027年）

Global Biopuncture Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5621 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、バイオパンクチャー治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルニカ、エキナセア、カモミール、その他）、用途別市場規模（婦人科系疾患、精神科系疾患、筋骨格系疾患、整形外科系疾患、消化器系疾患...

世界のリウマチ疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Rheumatic Disorders Drug Market Size, Status and Forecast 2021-2027
QFJ1-5995 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、リウマチ疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍壊死因子-α作用型、インターロイキン・インターロイキン受容体作用型、プロテインキナーゼ作用型、細胞表面抗原作用型、ホルモン・ホルモ...

世界の糖原病（GSD）臨床試験市場規模・現状・予測（2021年-2027年）

Global Glycogen Storage Disorders (GSD) Clinical Trials Market Size, Status and Forecast 2021-2027
QFJ1-4266 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、糖原病（GSD）臨床試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬剤）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界の遺伝性遺伝性疾患用遺伝子治療市場規模・現状・予測（2021年-2027年） In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome. Gene therapy has the potential to cure …
世界の尿素サイクル異常症（UCD）治療市場規模・現状・予測（2021年-2027年） The urea cycle disorders are hereditary metabolic disorders caused by a deficiency of one of the enzymes in the urea cycle responsible for removing ammonia from the bloodstream. Market Analysis and Insights: Global Urea Cycle Disorders (UCD) Treatment Market The global Urea Cycle Disorders (UCD) Tre…
世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Frontotemporal Disorders Treatment Market The global Frontotemporal Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界のシトクロムP45011B2ミトコンドリア市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cytochrome P450 11B2 Mitochondrial Market The global Cytochrome P450 11B2 Mitochondrial market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の上肢障害治療市場規模・現状・予測（2021年-2027年） The upper extremities are multi-layered sheath-like parts formed by bones, muscles, vascular nerves, and superficial, deep fascia and skin. Can be divided into shallow and deep two-layer structure. Symptoms of upper extremity disease may include reduced ability to use the affected parts of the limb,…